Method for preparing acotiamide hydrochloride trihydrate

A technology for acotiamide hydrochloride trihydrate and compound, which is applied in the field of preparation of pharmaceutical compounds, can solve the problems of environmentally destructive substances, low demethylation yield, side reactions, etc. Good product stability and mild reaction conditions

Active Publication Date: 2014-04-09
CHINA RESOURCES SAIKE PHARMA
View PDF8 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantages of this patent are: (1) the use of thionyl chloride and ethylene dichloride are highly toxic and environmentally destructive substances; (2) the yield of demethylation is low (reported as 64.6%-86 %)
The preparatio...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing acotiamide hydrochloride trihydrate
  • Method for preparing acotiamide hydrochloride trihydrate
  • Method for preparing acotiamide hydrochloride trihydrate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Preparation of N-[2-(Diisopropylamino)ethyl]-2-N-phthalimide-1,3-thiazole

[0070] Add N,N-diisopropylethylenediamine (28.8g, 0.2mol) and 2-N-phthalimide-4-methoxycarbonyl-1,3-thiazole (54.6 g, 0.2mol), heated to 100°C for 6h, cooled to room temperature and poured the reaction mixture into isopropanol, stirred at room temperature for 10h, filtered to collect the precipitated crystals, and dried at 50°C for 10h to obtain the target Compound 73.10g, yield: 91.5%.

[0071] The LC-MS measurement ion current of the product is: 401.23 (M+1), 400.23 (23%), 399.23 (4%), elemental analysis: C content 60.13%, H content 5.99%, O content 11.99%, N content 14.01 %.

[0072] Preparation of N-[2-(Diisopropylamino)ethyl]-2-amino-1,3-thiazole

[0073] Add N-[2-(diisopropylamino)ethyl]-2-N-phthalimide-1,3-thiazole (41.4g, 0.1mol) prepared in Example 1 into the reaction flask and ethanol (1L), add hydrazine hydrate (14.6g, 0.3mol) dropwise at room temperature, react at 70°C for 8h aft...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for preparing an acotiamide hydrochloride trihydrate. The method comprises the following steps: 1, reacting a compound of a formula (1) and N,N-diisopropylethylamine (2) to obtain a compound (3); 2, performing two-site amino deprotection on the compound (3) to obtain a compound (4); 3, condensing the compound (4) and an acyl chloride derivative to obtain a compound (5); 4, further preparing the compound (5) to obtain the acotiamide hydrochloride trihydrate (6).

Description

technical field [0001] The patent of the present invention relates to the preparation of a pharmaceutical compound, in particular to a preparation method of acotiamide hydrochloride trihydrate, a drug for treating or preventing functional dyspepsia. Background technique [0002] Acotiamide hydrochloride, chemical name: N-[2-(diisopropylamino)ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino] -1,3-thiazole-4-carboxamide hydrochloride, usually in its trihydrate form, the structure of acotiamide hydrochloride trihydrate is as follows: [0003] [0004] Acotiamide hydrochloride trihydrate is an acetylcholinesterase inhibitor gastrokinetic drug jointly developed by Zeria Pharmaceutical Company of Japan and Astellas, that is, a drug for the treatment of functional dyspepsia. It is the first drug approved globally for the treatment of FD. The drug was first launched in Japan in June 2013 under the brand name Acofide. Functional dyspepsia (FD) refers to a group of common symptoms...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D277/56
CPCY02P20/55C07D277/56
Inventor 宋波黄建金李日东杨琰
Owner CHINA RESOURCES SAIKE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap